These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24928307)

  • 1. Perceptions regarding injection number and technique.
    Coop CA; Yip SK; Tankersley MS
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):227-8. PubMed ID: 24928307
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingual.
    Sánchez J
    Allergol Immunopathol (Madr); 2015; 43(5):436-41. PubMed ID: 25201758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous injection immunotherapy for optimal effectiveness.
    Nelson HS
    Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved patient adherence to subcutaneous allergen immunotherapy using a modified rush immunotherapy protocol.
    Teachout J; Vandegrift S; Schafer C; Uekert S; Gell K
    Ann Allergy Asthma Immunol; 2019 Mar; 122(3):347-349. PubMed ID: 30308317
    [No Abstract]   [Full Text] [Related]  

  • 6. Imported fire ant hypersensitivity: a 1-day rush immunotherapy schedule without premedication.
    Dietrich JJ; Moore LM; Nguyen S; Hagan LL; Tankersley MS
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):535-6. PubMed ID: 20084848
    [No Abstract]   [Full Text] [Related]  

  • 7. The dry needle technique.
    Coop CA; Yip SK; Tankersley MS
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):120-1. PubMed ID: 24950851
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of allergen injection immunotherapy in real life.
    Borghesan F; Manzotti G
    Eur Ann Allergy Clin Immunol; 2013 Apr; 45(2):63-4. PubMed ID: 23821836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Special aspects of immunotherapy in children].
    Ruëff F
    J Dtsch Dermatol Ges; 2006 Feb; 4(2):143-52; quiz 153-4. PubMed ID: 16503943
    [No Abstract]   [Full Text] [Related]  

  • 10. A retrospective review of veterans' adherence to allergen immunotherapy over 10 years.
    Guenechea-Sola M; Hariri SR; Galoosian A; Yusin JS
    Ann Allergy Asthma Immunol; 2014 Jan; 112(1):79-81. PubMed ID: 24331403
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allergy vaccination with only 4 injections per year].
    Krankenpfl J; 2005; 43(7-10):261-2. PubMed ID: 16515332
    [No Abstract]   [Full Text] [Related]  

  • 13. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.
    Kuna P; Kaczmarek J; Kupczyk M
    J Allergy Clin Immunol; 2011 Feb; 127(2):502-508.e1-6. PubMed ID: 21281874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stinging-insect hypersensitivity: a 20-year study of immunologic treatment.
    Mueller HL; Schmid WH; Rubinsztain R
    Pediatrics; 1975 Apr; 55(4):530-3. PubMed ID: 1128960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccination against allergies yields good symptom relief].
    Hedlin G; Arvidsson M
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1938-41. PubMed ID: 18681376
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to imported fire ant subcutaneous immunotherapy.
    Stokes SC; Quinn JM; Sacha JJ; White KM
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):165-7. PubMed ID: 23548525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific treatment in allergy].
    Barocci C; Berardinelli G
    Otorinolaringol Ital; 1965; 34(3):185-97. PubMed ID: 5862546
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.
    Sieber J; De Geest S; Shah-Hosseini K; Mösges R
    Curr Med Res Opin; 2011 Apr; 27(4):855-61. PubMed ID: 21323505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
    Massanari M; Nelson H; Casale T; Busse W; Kianifard F; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2010 Feb; 125(2):383-9. PubMed ID: 20159249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.